Live Breaking News & Updates on Ligand Pharmaceuticals Stock|Page 1
Stay updated with breaking news from Ligand pharmaceuticals stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) Director Nancy Ryan Gray sold 934 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $83.20, for a total value of $77,708.80. Following the completion of the transaction, the director now owns 5,633 shares in […] ....
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 5,873 shares of the company’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $86.01, for a total value of $505,136.73. Following the completion of the transaction, the chief financial officer now directly owns 23,882 […] ....
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $84.54, for a total transaction of $290,817.60. Following the sale, the insider now directly owns 100,421 shares of the company’s […] ....
Ligand Pharmaceuticals (NASDAQ:LGND) Posts Earnings Results, Beats Estimates By $3.01 EPS etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals (NASDAQ:LGND) Announces Earnings Results tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.